Cargando…

Selectivity to amyloid-β precursor protein cleavage provides hope against Alzheimer's

Toward development of a safe and effective treatment for Alzheimer's disease, Elan Pharmaceuticals reported a novel γ-secretase inhibitor that specifically targets the cleavage of amyloid-β precursor protein, opening the way to design of substrate-specific γ-secretase inhibitors that would redu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Taisuke, Wong, Philip C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226269/
https://www.ncbi.nlm.nih.gov/pubmed/21418547
http://dx.doi.org/10.1186/alzrt66

Ejemplares similares